Stock futures are little changed, with Nasdaq on pace to end 7-month win streak: Live updates

Stock futures are little changed, with Nasdaq on pace to end 7-month win streak: Live updates


Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., Nov. 26, 2025.

Brendan McDermid | Reuters

Stock futures were little changed Thursday night during a holiday shortened week, with the Nasdaq Composite on track to end a seven-month winning streak.

Dow Jones Industrial Average futures rose just 10 points. S&P 500 futures and Nasdaq-100 futures traded just above the flatline.

Stocks are on pace for a losing month when trading resumes on Friday. A pullback in tech stocks have weighed on the major averages in November, as doubt swirled around the future profitability of AI companies.

Yet some investors are hopeful that this month’s slide will mean a year-end rally is in store for the major averages, as they step into buy stocks that have been unduly punished at more attractive valuations.

As of Wednesday’s close, the Dow and the S&P 500 were slightly lower on the week, each set to snap six straight months of gains. The Nasdaq fell 2%, on track to end a seven month advance.

Stocks are on pace to wrap up a winning week, following a turnaround in tech names. As of Wednesday’s close, the Dow was up more than 2%. The S&P 500 and Nasdaq Composite were higher by 3% and 4%, respectively.

The stock market was closed Thursday for Thanksgiving Day. It will close early at 1p.m. ET on Friday.



Source

Revolution Medicines’ potential breakthrough pancreatic cancer drug succeeds in late-stage trial
World

Revolution Medicines’ potential breakthrough pancreatic cancer drug succeeds in late-stage trial

Pancreatic cancer, illustration Nemes Laszl | Science Photo Library | Getty Images Revolution Medicines‘ drug for pancreatic cancer succeeded in a highly anticipated Phase 3 trial, almost doubling the typical length of survival and slashing the risk of death by 60% versus chemotherapy, the company said Monday. RevMed said its daily pill, daraxonrasib, met all […]

Read More
UK ‘not supporting’ U.S. Iran blockade as France’s Macron confirms ‘multinational’ talks on the Strait of Hormuz
World

UK ‘not supporting’ U.S. Iran blockade as France’s Macron confirms ‘multinational’ talks on the Strait of Hormuz

U.S. President Donald Trump and British Prime Minister Keir Starmer hold a press conference following their meeting at Chequers, near Aylesbury, Britain, Sept. 18, 2025. Kevin Lamarque | Reuters The U.K. is “not supporting” the U.S. blockade of Iranian ports, Prime Minister Keir Starmer said on Monday, insisting that the country would not get “dragged […]

Read More
Treasury yields rise as collapse of Iran talks clouds inflation outlook
World

Treasury yields rise as collapse of Iran talks clouds inflation outlook

Treasury yields edged higher on Monday as the breakdown of negotiations between Iran and the U.S. clouded the inflation outlook once again. The yield on the 10-year U.S. Treasury note — the benchmark for government borrowing — was up more than 1 basis point at 4.333%. The 2-year Treasury note yield, which is more sensitive to short-term Federal Reserve interest rate […]

Read More